NCL Lessons Learned Workshop
June 2nd-3rd, 2011
Fisher Lane Conference Center
5635 Fishers Lane,
Rockville, MD 20852
NOTE: Parking is available adjacent to Fishers Lane at a cost of $6.00 per day.
Registrants are encouraged to consider reserving accommodations at the Hilton Rockville:
1750 Rockville Pike, Rockville, MD
The NCI's Alliance for Nanotechnology in Cancer is sponsoring an intensive two-day scientific workshop on translational issues in preclinical characterization of nanomaterials. The workshop is intended for scientists, graduate level and above, with experience with bio-nanotechnology. This workshop will publicize and promote the "lessons learned" at NCI's Nanotechnology Characterization Lab (NCL) from the testing of more than 200 nanotechnology-based candidate cancer treatments and diagnostics. The NCL performs physiochemical characterization, in vitro experiments and in vivo testing to support regulatory filings with the FDA.
Areas of focus:
- Nanotech CMC: determining appropriate tests for batch-to-batch consistency, surface characterization, etc.
- Linking physicochemical characterization to safety and efficacy
- Addressing FDA requirements for nanotechnology
- QA/QC for methods for nanotechnology characterization
- Nanomaterial ADME/Tox and PK
- In vitro and in vivo immunotoxicity of nanomaterials
Featuring sessions by:
- Piotr Grodzinski, NCI Alliance for Nanotechnology in Cancer
- Scott McNeil, NCL Director
- Anil Patri, NCL Chemist
- Stephan Stern, NCL Toxicologist
- Marina Dobrovolskaia, NCL Immunologist
- Invited speakers from industry, FDA, etc.